Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001125282-03-003824
Filing Date
2003-06-11
Accepted
2003-06-10 21:15:00
Documents
7
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A b324740_10ka.htm 10-K/A 1393247
3 GRAPHIC emptybox.gif GRAPHIC 1218
4 GRAPHIC tickedbox.gif GRAPHIC 1267
5 THUS AGREEMENT MADE THIS 9TH DAY OF NOVEMBER 1999 b324740_ex10-13.txt EX-10.13 65238
6 MANUFACTURING AGREEMENT b324740_ex10-14.txt EX-10.14 52497
7 ADDENDUM TO MANUFACTURING AGREEMENT b324740_ex10-15.txt EX-10.15 2743
8 EXHIBIT 23.1 b324740ex23_1.htm EX-23.1 2004
  Complete submission text file 0001125282-03-003824.txt   1520391
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

EIN.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23272 | Film No.: 03739737
SIC: 2836 Biological Products, (No Diagnostic Substances)